Karsten Buschard

Research Professor

Rigshospitalet

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Karsten Buschard is a Research Professor at Rigshospitalet in Denmark. His research primarily focuses on the mechanisms underlying type 1 diabetes, including the influence of TLR5 and sphingolipid enzymes on disease development. He has contributed to studies on the effects of probiotics and sulfatide in diabetes incidence and progression. His recent work also explores the impact of environmental factors, such as hibernation in brown bears, on metabolic health.

Articles (12)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2021

Year:

2020

Year:

2020

Collaborators (2)

Henrik Ullits Andersen

Chief Consultant

Steno Diabetes Center Copenhagen

DENMARK

View details

Morten Hostrup

Københavns Universitet

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Karsten Buschard

Research Interests

Contact this professor

About

Articles (12)

Effect of fenofibrate on residual beta cell function in adults and adolescents with newly diagnosed type 1 diabetes: a randomised clinical trial

TLR5 influences the development of type 1 diabetes

A direct effect of sulfatide against development of fibrosis

Probiotic treatment with viable α‐galactosylceramide‐producing Bacteroides fragilis reduces diabetes incidence in female nonobese diabetic mice

Importance of C24:2 sulfatide

Beta‐cell activity and development of Type 1 diabetes

Influence of sphingolipid enzymes on blood glucose levels, development of diabetes, and involvement of pericytes

Hibernation and plasma lipids in free-ranging brown bears–implications for diabetes

Sulfatide inhibits fibroblast growth, activation and oxidative stress induced by ectopic insulin

Genetic predisposition in the 2′-5′A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity

Insulin Independence in Newly Diagnosed Type 1 Diabetes Patient following Fenofibrate Treatment

PPARs and the Development of Type 1 Diabetes

Collaborators (2)

Henrik Ullits Andersen

Morten Hostrup

Make your next move.